Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
grade C 89.27 1.22% 1.08
NVS closed up 1.22 percent on Monday, July 15, 2019, on 1.65 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical NVS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 1.22%
Cup with Handle Other 1.22%
Stochastic Reached Oversold Weakness 1.22%
BB Squeeze Ended Range Expansion 1.22%
Below Lower BB Weakness 1.22%

Older signals for NVS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Biotechnology Health Pharmaceutical Industry Pharmaceuticals Drugs Infectious Diseases Medication Pharmacy Pharmaceutical Industry In China Pharmaceuticals Policy Neuroscience Active Pharmaceutical Ingredients Antibiotics Healthcare Products Over The Counter Drug Prescription Drug Alcon Contact Lenses Veterinary Products
Is NVS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 96.31
52 Week Low 74.97
Average Volume 1,854,166
200-Day Moving Average 87.4853
50-Day Moving Average 87.4134
20-Day Moving Average 91.218
10-Day Moving Average 90.789
Average True Range 1.2145
ADX 28.88
+DI 24.7612
-DI 32.9326
Chandelier Exit (Long, 3 ATRs ) 90.00650000000001
Chandelier Exit (Short, 3 ATRs ) 91.6735
Upper Bollinger Band 93.5399
Lower Bollinger Band 88.8961
Percent B (%b) 0.08
BandWidth 5.090881
MACD Line 0.4931
MACD Signal Line 1.0559
MACD Histogram -0.5628
Fundamentals Value
Market Cap 209.15 Billion
Num Shares 2.34 Billion
EPS 2.74
Price-to-Earnings (P/E) Ratio 32.58
Price-to-Sales 3.85
Price-to-Book 2.71
PEG Ratio 2.69
Dividend 2.72
Dividend Yield 3.05%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 90.41
Resistance 3 (R3) 90.33 89.88 90.22
Resistance 2 (R2) 89.88 89.59 89.92 90.16
Resistance 1 (R1) 89.57 89.41 89.73 89.65 90.09
Pivot Point 89.12 89.12 89.19 89.16 89.12
Support 1 (S1) 88.81 88.83 88.97 88.89 88.45
Support 2 (S2) 88.36 88.65 88.40 88.38
Support 3 (S3) 88.05 88.36 88.32
Support 4 (S4) 88.13